Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Tumor Board at the Center for Personalized Medicine Tübingen: a Prospective Observational Study

NCT03503149 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03503149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03503149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Tumor Board at the Center for Personalized Medicine Tübingen: a Prospective Observational Study
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2018
Completion date
March 1, 2028
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer